Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schuster

Showing results (991-1000 of 1,019) with videos related to

Pageof 102
Sort By:
Trauma Surgery & Acute Care Open|July 6, 2026
Adopting common data elements for the National Trauma Research Repository through a consensus meeting: the trauma coreJohn David Cull, Pamela J Bixby, Nee-Kofi Mould-Millman, et al.
Lancet (London, England)|May 10, 2021
<sup>18</sup>F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trialAshesh B Jani, Eduard Schreibmann, Subir Goyal, et al.
Journal of the American College of Radiology : JACR|May 5, 2018
ACR Appropriateness Criteria<sup>®</sup> Pretreatment Staging of Muscle-Invasive Bladder Cancer, Christian B van der Pol, V Anik Sahni, et al.
Cancer|November 30, 2018
Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international studyOri Barzilai, Anne L Versteeg, Arjun Sahgal, et al.
European Urology|December 18, 2025
[<sup>18</sup>F]-Fluciclovine or [<sup>68</sup>Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 TrialAshesh B Jani, Vishal R Dhere, Subir Goyal, et al.
The Spine Journal : Official Journal of the North American Spine Society|June 10, 2026
Minimal clinically important differences in the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) in patients with symptomatic spinal metastasesA L Versteeg, A Sahgal, I Laufer, et al.
The Lancet. Oncology|September 13, 2024
[<sup>89</sup>Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialBrian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, et al.
Acta Pharmaceutica Sinica. B|October 24, 2025
Imaging poly(ADP-ribose) polymerase-1 (PARP1) <i>in vivo</i> with <sup>18</sup>F-labeled brain penetrant positron emission tomography (PET) ligandXin Zhou, Jiahui Chen, Jimmy S Patel, et al.
The Journal of Trauma and Acute Care Surgery|April 30, 2024
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter studyJordan M Estroff, Joseph Devlin, Lara Hoteit, et al.
The Journal of Trauma and Acute Care Surgery|July 13, 2026
Western Trauma Association critical decisions in trauma: Lung injuryAllyson M Hynes, John P Kuckelman, Raul Coimbra, et al.
Pageof 102

Showing results (991-1000 of 1,019) with videos related to

Sort By:
Pageof 102
Trauma Surgery & Acute Care Open|July 6, 2026
Adopting common data elements for the National Trauma Research Repository through a consensus meeting: the trauma coreJohn David Cull, Pamela J Bixby, Nee-Kofi Mould-Millman, et al.
Lancet (London, England)|May 10, 2021
<sup>18</sup>F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trialAshesh B Jani, Eduard Schreibmann, Subir Goyal, et al.
Journal of the American College of Radiology : JACR|May 5, 2018
ACR Appropriateness Criteria<sup>®</sup> Pretreatment Staging of Muscle-Invasive Bladder Cancer, Christian B van der Pol, V Anik Sahni, et al.
Cancer|November 30, 2018
Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international studyOri Barzilai, Anne L Versteeg, Arjun Sahgal, et al.
European Urology|December 18, 2025
[<sup>18</sup>F]-Fluciclovine or [<sup>68</sup>Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 TrialAshesh B Jani, Vishal R Dhere, Subir Goyal, et al.
The Spine Journal : Official Journal of the North American Spine Society|June 10, 2026
Minimal clinically important differences in the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) in patients with symptomatic spinal metastasesA L Versteeg, A Sahgal, I Laufer, et al.
The Lancet. Oncology|September 13, 2024
[<sup>89</sup>Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trialBrian Shuch, Allan J Pantuck, Jean-Christophe Bernhard, et al.
Acta Pharmaceutica Sinica. B|October 24, 2025
Imaging poly(ADP-ribose) polymerase-1 (PARP1) <i>in vivo</i> with <sup>18</sup>F-labeled brain penetrant positron emission tomography (PET) ligandXin Zhou, Jiahui Chen, Jimmy S Patel, et al.
The Journal of Trauma and Acute Care Surgery|April 30, 2024
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter studyJordan M Estroff, Joseph Devlin, Lara Hoteit, et al.
The Journal of Trauma and Acute Care Surgery|July 13, 2026
Western Trauma Association critical decisions in trauma: Lung injuryAllyson M Hynes, John P Kuckelman, Raul Coimbra, et al.
Pageof 102